A Research Trial of High Dose Vitamin C and Chemotherapy for Metastatic Pancreatic Cancer

Completed · Phase 1

Conditions studied: Pancreatic Neoplasms

In brief

This study is designed to determine the maximum tolerated dose of vitamin C when given with a standard chemotherapy for people who have metastatic pancreatic cancer.

Key facts

Study ID

NCT01049880

Run by

Joseph J. Cullen

People needed

15

Starts

2009-12-01

Expected to finish

2013-03-01

Last updated by the study team

2017-04-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Normal G6PD status
• Histologically or cytologically diagnosed pancreatic adenocarcinoma.
• Disease extent documented by CT scan (radiologically measurable disease is not required)
• Ambulatory patient without evidence of spinal cord compression
• No prior chemotherapy for metastatic disease
• Failed curative therapy or patient ineligible for definitive curative therapy
• Completed adjuvant therapy at least 4 weeks prior and recovered from any/all toxicities related to that treatment.
• If post-therapy, must have disease progression since that treatment
• If treated with prior radiation therapy, disease must be outside of the radiation fields
• No currently active second malignancies unless it is a non-melanoma skin cancer
• Women must be non-pregnant and non-lactating
• ECOG performance of 0, 1, or 2
• Granulocytes at least 1,500 / ul
• Platelets at least 100,000 / ul
• Creatinine less than 1.5 mg/dL or clearance of at least 60 mL / min
• Total bilirubin less than 2 times the upper limit of normal
• AST and ALT less than 3 times the upper limit of normal if liver metastases are not present. If liver metastases are present, AST and ALT less than 5 times the upper limit of normal
• PT INR less than 1.5 (unless the patient is on full dose warfarin)
• Patient must be at least 18 years of age
• Patient must be able to understand consent process, the research study, and be able to sign the consent document

You may not qualify if…

• A psychiatric disorder by history or examination that would prevent completion of the study
• ECOG performance of 3 or 4
• Co-morbid conditions that affect survival: end stage congestive heart failure, unstable angina, myocardial infarction (within the past 6 weeks), uncontrolled blood sugars of greater than 300 mg/dL, known chronic active hepatitis or cirrhosis.
• Consumption of excess alcohol (more than 4 drinks per day) or use of illicit drugs
• Continued sse of over-the-counter antioxidants (supplements like vitamin C and grape seeds)

Where it is running

• The University of Iowa Hospitals & Clinics — Iowa City, Iowa, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.